Biopharma Informatics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.30 M
as on 16-11-2024
- Company Age 23 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 221.27%
(FY 2023)
- Ebitda 221.31%
(FY 2023)
- Net Worth 231.79%
(FY 2023)
- Total Assets 41.77%
(FY 2023)
About Biopharma Informatics
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Gokaraju Raju, Gokaraju Raju, and Gokaraju Raju serve as directors at the Company.
- CIN/LLPIN
U93190KA2001PTC029006
- Company No.
029006
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biopharma Informatics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gokaraju Raju  | Director | 14-May-2001 | Current |
| Gokaraju Raju | Director | 14-Jun-2001 | Current |
| Gokaraju Raju | Director | 14-May-2001 | Current |
Financial Performance of Biopharma Informatics.
Biopharma Informatics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 221.27% increase in profit. The company's net worth Soared by an impressive increase of 231.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biopharma Informatics?
In 2023, Biopharma Informatics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Light Pharma Private LimitedActive 19 years 8 monthsGokaraju Raju, Gokaraju Raju and 1 more are mutual person
- Sound Investment And Leasing Private LimitedActive 40 years 10 months
Gokaraju Raju and Gokaraju Raju are mutual person
- Dhi Innovations Private LimitedActive 53 years 11 months
Gokaraju Raju, Gokaraju Raju and 1 more are mutual person
- Systems And Equipments Private LimitedActive 45 years 3 months
Gokaraju Raju and Gokaraju Raju are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biopharma Informatics?
Unlock and access historical data on people associated with Biopharma Informatics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biopharma Informatics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biopharma Informatics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
